What is OptimizeRx's payments to develop software?

OptimizeRx (OPRX) reported payments to develop software of $0 in Q1 2026.

How has OptimizeRx's payments to develop software changed year-over-year?

OptimizeRx's payments to develop software decreased by 100.0% year-over-year, from $57K to $0.

What is the long-term trend for OptimizeRx's payments to develop software?

Over 3 years (2021 to 2024), OptimizeRx's payments to develop software has grown at a -2.5% compound annual growth rate (CAGR), from $364.17K to $338K.

OptimizeRx OPRX Payments to Develop Software

Payments to Develop Software at other companies

PhreesiaPHR

$3.24M-16.7%

DoximityDOCS

$2.25M+49.5%

PubMaticPUBM

$6.58M-4.4%

TruBridge, Inc.TBRG

$2.65M-33.5%

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToDevelopSoftware.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's payments to develop software.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's payments to develop software?: OptimizeRx (OPRX) reported payments to develop software of $0 in Q1 2026.
How has OptimizeRx's payments to develop software changed year-over-year?: OptimizeRx's payments to develop software decreased by 100.0% year-over-year, from $57K to $0.
What is the long-term trend for OptimizeRx's payments to develop software?: Over 3 years (2021 to 2024), OptimizeRx's payments to develop software has grown at a -2.5% compound annual growth rate (CAGR), from $364.17K to $338K.